---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-23-000029"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T05:24:53.522650+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q2 revenue $549.3M (-2% YoY); adjusted EPS $1.88 vs $1.37; narrows FY23 guidance

## Summary
- Revenue $549.3M vs $561.0M YoY; GAAP gross margin improved to 35% from 30%.
- GAAP net loss $(9.9)M ($(0.41)/share) vs $(7.5)M ($(0.31)/share) YoY.
- Adjusted diluted EPS $1.88 vs $1.37; adjusted EBITDA $98.1M vs $84.7M.
- Company narrows fiscal year 2023 guidance ranges for revenue and adjusted EPS.

## SEC filing metadata
- accession: 0000883984-23-000029
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398423000029/0000883984-23-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398423000029/icui-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-23-000029
- JSON: https://secwatch.observer/filing/0000883984-23-000029.json
- Plain text: https://secwatch.observer/filing/0000883984-23-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.